ATCC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms, cell lines and other materials. Its products include nucleic acids, cells and microorganisms, testing and characterization, cells extracts, culture reagents, quality control strains, proteins and cell extracts. ATCCs services include production and characterization, biorepository management, testing services, and deposit services. The organization offers custom testing services for mycoplasma detection and human cell line authentication. It serves research and life science industry. The organization also provides storage of biomaterials through its facility. ATCC is headquartered in Manassas, Virginia, the US.

ATCC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATCC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ATCC, Medical Devices Deals, 2012 to YTD 2018 8
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ATCC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Horizon Discovery Enters Into Licensing Agreement With ATCC 10
ATCC Forms Joint Venture with ILSE 11
BioCision Enters Into Co-Development Agreement With ATCC 12
Licensing Agreements 13
Biomatrica Enters Into Licensing Agreement With ATCC For DNAstable And RNAstable Reagents 13
ATCC Enters into Licensing Agreement with Baylor College of Medicine 14
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 15
ATCC - Key Competitors 16
ATCC - Key Employees 17
ATCC - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Recent Developments 19
Strategy And Business Planning 19
Apr 21, 2017: ATCC Opens Doors to New High-Tech Biorepository in Gaithersburg, MD 19
Product News 20
Nov 20, 2017: ATCC develops novel in vitro model to investigate drug candidates for cancer metastasis 20
Other Significant Developments 21
Jul 10, 2018: ATCC launches new PCR-based Mycoplasma Detection Service 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List Of Tables


ATCC, Pharmaceuticals & Healthcare, Key Facts 2
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATCC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ATCC, Medical Devices Deals, 2012 to YTD 2018 8
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Horizon Discovery Enters Into Licensing Agreement With ATCC 10
ATCC Forms Joint Venture with ILSE 11
BioCision Enters Into Co-Development Agreement With ATCC 12
Biomatrica Enters Into Licensing Agreement With ATCC For DNAstable And RNAstable Reagents 13
ATCC Enters into Licensing Agreement with Baylor College of Medicine 14
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 15
ATCC, Key Competitors 16
ATCC, Key Employees 17
ATCC, Joint Venture 18

List Of Figures


ATCC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATCC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ATCC, Medical Devices Deals, 2012 to YTD 2018 8

ATCC - Pharmaceuticals and Healthcare - Deals and Alliances Profile

ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms,

USD 250 View Report

ATCC - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms,

USD 250 View Report

ICT Investment Trends - Pharmaceuticals

ICT Investment Trends - PharmaceuticalsICT Investment Trends in Pharmaceuticals a Customer Insight Survey report is one of the many products in the Digital Industry product portfolio, which provides an executive-level

USD 2995 View Report

Kazia Therapeutics Ltd (KZA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kazia Therapeutics Limited (Kazia Therapeutics), is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on three drug technology

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available